Traumatic Brain Injury & the Gut Microbiome

Status Completed

Clinical Trial Summary

The purpose of the study is to determine whether administration of a prebiotic, inulin, can improve the symptom complex associated with traumatic brain injury and whether inulin administration can alter the bacteria that live in the gut.

Clinical Trial Description

The investigators will study subjects (aged 18-70 years) with a history of moderate/severe traumatic brain injury (n=10) and healthy controls (aged 18-70 years) (n=10). All subjects will undergo a 3-month intervention of oral inulin treatment. The traumatic brain injury subjects will be administered oral inulin twice daily for 3 months. Testing including cognitive function assessment (Repeatable Battery for the Assessment of Neuropsychological Status (RBANS), and questionnaires of fatigue, mood and quality of life and sleep will occur at month 0, 3 and 6. Blood sampling for measurement of amino acid levels, hormones, short chain fatty acids and markers of neuroinflammation will be drawn before and 90 minutes (+/- 10 minutes) after a standardized meal will occur at month 0 and month 3. In addition, fecal samples for analysis of the GI microbiome will be collected at month -1, month 0, month 1, month 2, month 3, and month 6 along with an assessment of gastrointestinal health. Traumatic brain injury subjects will be selected from residents at a long term residential rehabilitation center. Healthy control subjects will be administered oral inulin twice daily with meals for 3 months. Quality of life will be assessed by questionnaires at months 0, 3 and 6. Blood sampling for measurement of amino acid levels, hormones, short chain fatty acids and markers of neuroinflammation will be drawn before and 90 minutes (+/- 10 minutes) after a standardized meal will occur at month 0 and month 3. Fecal samples will be collected at month -1, month 0, month 3 and month 6 for analysis of the GI microbiome along with an assessment of gastrointestinal health. A member of the study team will check monthly for adverse events and overall well-being and ensure compliance and ongoing consent. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04949607
Study type	Interventional
Source	Centre for Neuro Skills
Contact
Status	Completed
Phase	N/A
Start date	July 28, 2021
Completion date	June 8, 2022

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04111549` - GOALS Cognitive Training Delivered to Aging Veterans in Person or Via Telehealth	N/A
Recruiting	`NCT05097261` - Ketamine in Acute Brain Injury Patients.	Phase 4
Completed	`NCT03504709` - REsting and Stimulus-based Paradigms to Detect Organized NetworkS and Predict Emergence of Consciousness
Recruiting	`NCT03899532` - Remote Ischemic Conditioning in Traumatic Brain Injury	N/A
Completed	`NCT05057377` - Estimating Highest Capacity Performance During Evaluation of Walking for Individuals With Traumatic Brain Injury
Withdrawn	`NCT02776488` - Exogenous Sodium Lactate Infusion in Traumatic Brain Injury (ELI-TBI)	Phase 2
Completed	`NCT02426749` - Treatment and Recovery Monitoring of Post TBI Symptoms	N/A
Completed	`NCT01339702` - The EPIC Project: Impact of Implementing the EMS Traumatic Brain Injury Treatment Guidelines
Recruiting	`NCT05977270` - The Effects of Lifebloom One on Physical Activity After Acquired Brain Injury	N/A
Recruiting	`NCT04666766` - Detecting Traumatic Intracranial Hemorrhage With Microwaves and Biomarkers	N/A
Active, not recruiting	`NCT04559724` - Gait Training Through a Novel Over-ground Wearable Robotic System in People With Pyramidal Hemisyndromes	N/A
Not yet recruiting	`NCT04515420` - The Influence of Noradrenaline on Coagulation and Fibrinolysis in Severe Isolated Brain Injury
Not yet recruiting	`NCT05569993` - Glutamine and Traumatic Brain Injury	Early Phase 1
Recruiting	`NCT04331392` - Online Memory Intervention for Individuals With Traumatic Brain Injury	N/A
Completed	`NCT03727737` - Efficacy of Repetitive Transcranial Magnetic Stimulation for Improvement of Memory in Older Adults With TBI	N/A
Completed	`NCT03153397` - Effect of Prebiotic Fiber- Enriched (scFOS) Enteral Feeding on the Microbiome in Neurological Injury Trauma Patients (PreFEED Microbiome Trial)	N/A
Completed	`NCT01336413` - Neuroactive Steroids and Traumatic Brain Injury (TBI) in OEF/OIF Veterans	Phase 2
Completed	`NCT02004080` - CREACTIVE - Collaborative REsearch on ACute Traumatic Brain Injury in intensiVe Care Medicine in Europe
Completed	`NCT04957563` - Clinical Utility of Olfactory Rehabilitation: Treatment for Pacients With Neurosensorial Anosmia	N/A
Completed	`NCT05179330` - Visual Feedback in Lower Limb Rehabilitation	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Traumatic Brain Injury and the Gut Microbiome

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms